Losartan + Paclitaxel for fallopian tube neoplasms

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 5 Dec 2025: Trial registered, NCT07265739

The trials

NCT07265739: Losartan and Paclitaxel in Platinum Resistant Ovarian Cancer

State
Not started
Phase
Phase 2
People
27 planned
Started
Feb 2027
Primary completion
30 Dec 2027
Arms
Losartan + Paclitaxel
Results
None posted
  1. 5 Dec 2025: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.